Fierce Biotech August 23, 2024
Welcome to this week’s Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren Incorvaia or Gabrielle Masson and it will be featured here at the end of each week.
BioMarin builds up with biotech leaders
BioMarin Pharmaceutical
Coastal California biotech BioMarin Pharmaceutical is bringing two biotech vets on board to lead its new-look R&D and deals teams. The two people joining the company are Greg Friberg, M.D., and James Sabry, M.D., Ph.D. Friberg, who spent 18 years at Amgen, will take the title of chief research and development officer, replacing the retiring Hank Fuchs, M.D. Sabry, who left Roche in May after...
Today's Sponsors
Today's Sponsor